# Korean Post-marketing Surveillance for Kombiglyze XR®

> **NCT01754142** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 755 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01754142
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-11-24
- **Primary completion:** 2016-09-01
- **Final completion:** 2016-09-01
- **Target enrollment:** 755 (ACTUAL)
- **Last updated:** 2017-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01754142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01754142, "Korean Post-marketing Surveillance for Kombiglyze XR®". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01754142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*